RxDoctor Payments Data

Alan Colvin, PA

Physician Assistant · Raleigh, NCNPI 1033879150

Payments from drug & device makers

$1,727in general payments, 2019–2025

Across 89 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$327
  • AbbVie$228
  • Lilly USA, LLC$172
  • Boehringer Ingelheim$132
  • Astellas Pharma US Inc$111
  • Pfizer$103
  • plus $656 from 15 others

What the payments were for

  • Food & beverage$1,71599%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,727 in reported general payments places this provider in the 75th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$32,901
Medicare patients
116
Services billed
539

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$59,494
JardianceEmpagliflozin31$52,432
MounjaroTirzepatide27$27,829
EliquisApixaban19$26,378
XareltoRivaroxaban32$22,244
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$10,221
Potassium Citrate ErPotassium Citrate12$2,667
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$2,376
Celecoxib17$1,855
Atorvastatin Calcium203$1,670
SynthroidLevothyroxine Sodium21$1,424
Gabapentin49$1,094
Amlodipine Besylate124$1,003
Levothyroxine Sodium68$989
Rosuvastatin Calcium59$973

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$327$59,49439 claims
Boehringer IngelheimJardiance$132$52,43231 claims
Lilly USA, LLCMounjaro$172$27,82927 claims
PfizerEliquis$103$26,37819 claims
GSKTrelegy Ellipta$50$10,22112 claims
AbbVieSynthroid$228$1,42421 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →